View source for Theriva Biologics, Inc. Patent Application Trends in 2024

== Theriva Biologics, Inc. Patent Filing Activity ==
== Theriva Biologics, Inc. patent applications in 2024 ==
[[File:Theriva Biologics, Inc. Monthly Patent Applications 2024 - Up to June 2024.png|border|800px]]
== Top 10 Technology Areas ==
[[File:Theriva Biologics, Inc. Top Technology Areas 2024 - Up to June 2024.png|border|800px|Theriva Biologics, Inc. Top Technology Areas 2024 - Up to June 2024]]

* [[:Category:CPC_A61K38/50|A61K38/50]] (No explanation available)
** Count: 2 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K9/5078|A61K9/5078]] (No explanation available)
** Count: 2 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K45/06|A61K45/06]] (No explanation available)
** Count: 2 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K9/5026|A61K9/5026]] (No explanation available)
** Count: 2 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_C12Y305/02006|C12Y305/02006]] (No explanation available)
** Count: 2 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K9/1652|A61K9/1652]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/4164|A61K31/4164]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/424|A61K31/424]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/43|A61K31/43]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/7056|A61K31/7056]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
== Emerging Technology Areas ==
[[File:Theriva Biologics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024.png|border|800px|Theriva Biologics, Inc. Top Emerging Technology Areas 2024 - Up to June 2024]]

* [[:Category:CPC_A61K31/546|A61K31/546]] (No explanation available)
** Count: 1 patents
** Example: [[20240082370. SAFE AND EFFECTIVE BETA-LACTAMASE DOSING FOR MICROBIOME PROTECTION simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K9/5047|A61K9/5047]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K38/14|A61K38/14]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K35/741|A61K35/741]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K35/74|A61K35/74]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/7056|A61K31/7056]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/43|A61K31/43]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/424|A61K31/424]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K31/4164|A61K31/4164]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
* [[:Category:CPC_A61K9/1652|A61K9/1652]] (No explanation available)
** Count: 1 patents
** Example: [[20240197842. METHOD AND COMPOSITIONS FOR INHIBITING OR PREVENTING ADVERSE EFFECTS OF ORAL ANTIBIOTICS simplified abstract (Theriva Biologics, Inc.)]]
== Top Inventors ==
[[File:Theriva Biologics, Inc. Top Inventors 2024 - Up to June 2024.png|border|800px|Theriva Biologics, Inc. Top Inventors 2024 - Up to June 2024]]
* [[:Category:Michael KALEKO of Rockville MD (US)|Michael KALEKO of Rockville MD (US)]] (1 patent)
* [[:Category:Sheila CONNELLY of Rockville MD (US)|Sheila CONNELLY of Rockville MD (US)]] (1 patent)
* [[:Category:Vincent John WACHER of Rockville MD (US)|Vincent John WACHER of Rockville MD (US)]] (1 patent)
* [[:Category:Joseph Sliman of Rockville MD (US)|Joseph Sliman of Rockville MD (US)]] (1 patent)
== Patent Categories ==
[[File:Theriva Biologics, Inc. Patent Categories 2024 - Up to June 2024.png|border|500px|Theriva Biologics, Inc. Patent Categories 2024 - Up to June 2024]]

== Geographical Distribution of Inventors ==
[[File:Theriva Biologics, Inc. Inventor Countries 2024 - Up to June 2024.png|border|800px|Theriva Biologics, Inc. Inventor Countries 2024 - Up to June 2024]]

== Geographical Distribution of US Inventors ==
[[File:Theriva Biologics, Inc. Inventor States 2024 - Up to June 2024.png|border|800px|Theriva Biologics, Inc. Inventor States 2024 - Up to June 2024]]

[[Category:Theriva Biologics, Inc.]]
[[Category:Companies]]
[[Category:CPC_A61K38/50]]
[[Category:CPC_A61K9/1652]]
[[Category:CPC_A61K9/5078]]
[[Category:CPC_A61K31/4164]]
[[Category:CPC_A61K31/424]]
[[Category:CPC_A61K31/43]]
[[Category:CPC_A61K31/7056]]
[[Category:CPC_A61K35/74]]
[[Category:CPC_A61K35/741]]
[[Category:CPC_A61K38/14]]
[[Category:CPC_A61K45/06]]
[[Category:CPC_A61K9/5026]]
[[Category:CPC_A61K9/5047]]
[[Category:CPC_C12Y305/02006]]
[[Category:CPC_A61K31/546]]
[[Category:Patent Trends by Company in 2024]]